Priya Mahajan

Canal Road
Jammu, JK 180001, India

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 23 publications

Correction to "Design of Novel 3-Pyrimidinylazaindole CDK2/9 Inhibitors with Potent In Vitro and In Vivo Antitumor Efficacy in a Triple-Negative Breast Cancer Model".

Correction to "Design of Novel 3-Pyrimidinylazaindole CDK2/9 Inhibitors with Potent In Vitro and In Vivo Antitumor Efficacy in a Triple-Negative Breast Cancer Model".

Journal: Journal of medicinal chemistry

Published: March 26, 2026

Comparative Evaluation of the Efficacy of Two Modes of Delivery of Diclofenac for the Management of Post-Endodontic Pain: A Randomized Controlled Clinical Trial.

Comparative Evaluation of the Efficacy of Two Modes of Delivery of Diclofenac for the Management of Post-Endodontic Pain: A Randomized Controlled Clinical Trial.

Journal: Journal of pharmacy & bioallied sciences

Published: February 06, 2023

Nanotechnology and its challenges in the food sector: a review.

Nanotechnology and its challenges in the food sector: a review.

Journal: Materials today. Chemistry

Published: January 02, 2020

Corrigendum to "Design, synthesis and biological evaluation of pyrazolopyrimidinone based potent and selective PDE5 inhibitors for treatment of erectile dysfunction" [Bioorg. Chem. 89 (2019) 103022].

Corrigendum to "Design, synthesis and biological evaluation of pyrazolopyrimidinone based potent and selective PDE5 inhibitors for treatment of erectile dysfunction" [Bioorg. Chem. 89 (2019) 103022].

Journal: Bioorganic chemistry

Published: September 17, 2019

Asymmetrical interval type-2 fuzzy logic control based MPPT tuning for PV system under partial shading condition.

Asymmetrical interval type-2 fuzzy logic control based MPPT tuning for PV system under partial shading condition.

Journal: ISA transactions

Published: May 03, 2019

Rottlerin is a pan phosphodiesterase inhibitor and can induce neurodifferentiation in IMR-32 human neuroblastoma cells.

Rottlerin is a pan phosphodiesterase inhibitor and can induce neurodifferentiation in IMR-32 human neuroblastoma cells.

Journal: European journal of pharmacology

Published: March 03, 2019

Design, synthesis and biological evaluation of pyrazolopyrimidinone based potent and selective PDE5 inhibitors for treatment of erectile dysfunction.

Design, synthesis and biological evaluation of pyrazolopyrimidinone based potent and selective PDE5 inhibitors for treatment of erectile dysfunction.

Journal: Bioorganic chemistry

Published: February 11, 2019

Combining ligand- and structure-based in silico methods for the identification of natural product-based inhibitors of Akt1.

Combining ligand- and structure-based in silico methods for the identification of natural product-based inhibitors of Akt1.

Journal: Molecular diversity

Published: October 09, 2018

Design of Novel 3-Pyrimidinylazaindole CDK2/9 Inhibitors with Potent In Vitro and In Vivo Antitumor Efficacy in a Triple-Negative Breast Cancer Model.

Design of Novel 3-Pyrimidinylazaindole CDK2/9 Inhibitors with Potent In Vitro and In Vivo Antitumor Efficacy in a Triple-Negative Breast Cancer Model.

Journal: Journal of medicinal chemistry

Published: November 17, 2017

Design and synthesis of 1,4-substituted 1H-1,2,3-triazolo-quinazolin-4(3H)-ones by Huisgen 1,3-dipolar cycloaddition with PI3Kγ isoform selective activity.

Design and synthesis of 1,4-substituted 1H-1,2,3-triazolo-quinazolin-4(3H)-ones by Huisgen 1,3-dipolar cycloaddition with PI3Kγ isoform selective activity.

Journal: Bioorganic & medicinal chemistry letters

Published: November 09, 2017

Fusion of Structure and Ligand Based Methods for Identification of Novel CDK2 Inhibitors.

Fusion of Structure and Ligand Based Methods for Identification of Novel CDK2 Inhibitors.

Journal: Journal of chemical information and modeling

Published: July 21, 2017

Exploring Derivatives of Quinazoline Alkaloid l-Vasicine as Cap Groups in the Design and Biological Mechanistic Evaluation of Novel Antitumor Histone Deacetylase Inhibitors.

Exploring Derivatives of Quinazoline Alkaloid l-Vasicine as Cap Groups in the Design and Biological Mechanistic Evaluation of Novel Antitumor Histone Deacetylase Inhibitors.

Journal: Journal of medicinal chemistry

Published: April 04, 2017

Showing 1-12 of 23

Last Updated: 09/26/2026